Literature DB >> 26087743

Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.

Zhen Li1, Xiao-Bai Liu, Yun-hui Liu, Yi-xue Xue, Ping Wang, Li-bo Liu, Jing Liu, Yi-long Yao, Jun Ma.   

Abstract

Previous studies have demonstrated that low-dose endothelial monocyte-activating polypeptide-II (EMAP-II) induces blood-tumor barrier (BTB) opening via RhoA/Rho kinase/PKC-α/β signaling pathway. In a recent study, we revealed that low-dose EMAP-II induced significant increases in expression levels of serine/threonine (Ser/Thr) phosphatase (PP)1 and 2A in rat brain microvascular endothelial cells (RBMECs) of BTB model. In addition, PKC-ζ/PP2A signaling pathway is involved in EMAP-II-induced BTB hyperpermeability. The present study further investigated the exact roles of PPs in this process. In an in vitro BTB model, low-dose EMAP-II (0.05 nM) induced a significant increase in PP1 activity in RBMECs. There was an interaction between PKC-α/β and PP1 in RBMECs. Inhibition of PKC-α/β activity with GÖ6976 completely blocked EMAP-II-induced activation of PP1. Conversely, inhibition of PP1 activity with tautomycin had no effect on EMAP-II-induced PKC-α/β activation. Like GÖ6976, tautomycin significantly prevented EMAP-II-induced BTB hyperpermeability and MLC phosphorylation in RBMECs. Also, in this study, EMAP-II induced a marked redistribution of occludin and a significant dephosphorylation of occludin on Ser/Thr residues in RBMECs. Similar with GÖ6976 pretreatment, tautomycin pretreatment dramatically diminished EMAP-II-induced redistribution of occludin. Furthermore, pretreatment with tautomycin significantly inhibited EMAP-II-induced dephosphorylation of occludin on Ser residues. However, pretreatment with okadaic acid (an inhibitor of PP2A) significantly prevented changes in Ser-phosphorylated occludin induced by EMAP-II treatment. Collectively, this study demonstrates that low-dose EMAP-II increases BTB permeability via a RhoA/Rho kinase/PKC-α/β/PP1 signaling pathway and that PP1/PP2A-mediated Ser/Thr dephosphorylation of occludin plays an important role in EMAP-II-induced BTB hyperpermeability.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26087743     DOI: 10.1007/s12031-015-0604-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions.

Authors:  I Simonovic; J Rosenberg; A Koutsouris; G Hecht
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

2.  Phosphorylation of occludin correlates with occludin localization and function at the tight junction.

Authors:  V Wong
Journal:  Am J Physiol       Date:  1997-12

3.  Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.

Authors:  Zhen Li; Yun-Hui Liu; Xiao-Bai Liu; Yi-Xue Xue; Ping Wang; Li-Bo Liu
Journal:  Exp Cell Res       Date:  2015-01-12       Impact factor: 3.905

4.  Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis.

Authors:  Gang Zhou; George Kamenos; Suresh Pendem; John X Wilson; Feng Wu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-23       Impact factor: 3.619

5.  Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells.

Authors:  F V Härtel; C W Rodewald; M Aslam; D Gündüz; L Hafer; J Neumann; H M Piper; T Noll
Journal:  Cardiovasc Res       Date:  2007-02-20       Impact factor: 10.787

6.  Possible involvement of phosphorylation of occludin in tight junction formation.

Authors:  A Sakakibara; M Furuse; M Saitou; Y Ando-Akatsuka; S Tsukita
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

7.  Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.

Authors:  Hui Xie; Yi-Xue Xue; Li-Bo Liu; Yun-Hui Liu
Journal:  Brain Res       Date:  2010-01-18       Impact factor: 3.252

8.  Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex.

Authors:  Andrei I Ivanov; Ingrid C McCall; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

9.  Disruption of epithelial tight junctions by yeast enhances the paracellular delivery of a model protein.

Authors:  Emily Fuller; Craig Duckham; Edward Wood
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.580

10.  Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.

Authors:  Niranjan Awasthi; Changhua Zhang; Winston Ruan; Margaret A Schwarz; Roderich E Schwarz
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

View more
  8 in total

1.  EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.

Authors:  Qi Yu; Libo Liu; Ping Wang; Yilong Yao; Yixue Xue; Yunhui Liu
Journal:  Cell Cycle       Date:  2017-04-24       Impact factor: 4.534

2.  The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.

Authors:  Jiahui Liu; Libo Liu; Shuo Chao; Yunhui Liu; Xiaobai Liu; Jian Zheng; Jiajia Chen; Wei Gong; Hao Teng; Zhen Li; Ping Wang; Yixue Xue
Journal:  Front Cell Neurosci       Date:  2017-12-19       Impact factor: 5.505

3.  Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.

Authors:  Wei Zhou; Libo Liu; Yixue Xue; Jian Zheng; Xiaobai Liu; Jun Ma; Zhen Li; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2017-03-13       Impact factor: 5.639

4.  MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.

Authors:  Liangyu Chen; Yixue Xue; Jian Zheng; Xiaobai Liu; Jing Liu; Jiajia Chen; Zhen Li; Zhuo Xi; Hao Teng; Ping Wang; Libo Liu; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2018-02-07       Impact factor: 5.639

Review 5.  Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer.

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Dongsheng Yu; Xiaochuan Zhang
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

6.  Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response.

Authors:  Carsten Hagemann; Nikolas Neuhaus; Mathias Dahlmann; Almuth F Kessler; Dennis Kobelt; Pia Herrmann; Matthias Eyrich; Benjamin Freitag; Thomas Linsenmann; Camelia M Monoranu; Ralf-Ingo Ernestus; Mario Löhr; Ulrike Stein
Journal:  Cancers (Basel)       Date:  2019-06-13       Impact factor: 6.639

7.  Changes in the expression of endothelial monocyte‑activating polypeptide II in the rat hippocampus following status epilepticus.

Authors:  Chun Li; Weining Ma; Yajuan Zhao; Hua Wang
Journal:  Int J Mol Med       Date:  2020-12-03       Impact factor: 4.101

8.  EMAP II Expression Is Increased on Peripheral Blood Cells from Non-Hodgkin Lymphoma.

Authors:  Manal Mohamed Saber
Journal:  J Immunol Res       Date:  2022-09-12       Impact factor: 4.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.